pDCs, type 1 IFN, and the female predileXion of SSc
The Journal of Experimental Medicine,
Journal Year:
2025,
Volume and Issue:
222(3)
Published: Jan. 17, 2025
Systemic
sclerosis
(SSc)
is
a
debilitating
autoimmune
disease
that
preferentially
afflicts
women.
The
molecular
origins
of
this
female
bias
are
unclear.
A
new
study
plasmacytoid
dendritic
cells
from
SSc
patients
by
Du
et
al.
(https://doi.org/10.1084/jem.20231809)
suggests
the
X
chromosome
may
play
key
role.
Language: Английский
More X’s, more problems: how contributions from the X chromosomes enhance female predisposition for autoimmunity
Current Opinion in Immunology,
Journal Year:
2025,
Volume and Issue:
93, P. 102543 - 102543
Published: Feb. 27, 2025
Language: Английский
Immuno’logique (l’actualité scientifique que vous n’auriez pas osé lire ailleurs) : chromosome X, Xist et auto-immunité féminine
La Revue de Médecine Interne,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 1, 2025
Language: Английский
Oxidative damage reprograms the Hippo-WNT network via X-linked Kdm6a to activate blastocyst dormancy and prevent offspring tumorigenesis.
Zhen Li,
No information about this author
Yue Huang,
No information about this author
Siyao Ha
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 24, 2025
Abstract
In
vitro
fertilization
(IVF)
has
been
associated
with
an
increased
risk
of
tumorigenesis
in
offspring.
Our
previous
research
indicated
that
oxidative
damage-induced
X-chromosome
aneuploidy
(XCA)
IVF
mouse
embryos
may
contribute
to
However,
the
tumorigenic
mechanisms
underlying
this
phenomenon
remain
unclear.
The
present
study
elucidates
elevated
number
X
chromosomes
leads
excessive
transcription
Xist,
resulting
aberrant
inactivation
(XCI).
This
abnormal
XCI
subsequently
inhibits
expression
X-linked
lysine
demethylase
6A
(Kdm6a),
which
is
followed
by
increase
repressive
marker
H3K27me3
and
a
decrease
active
markers
H3K27ac/H3K4me3.
To
investigate
epigenetic
involved
offspring
tumorigenesis,
we
employed
CUT&Tag
technology
map
genome-wide
profiles
H3K27ac/H3K4me3/H3K27me3
blastocysts.
We
found
Kdm6a-dependent
histone
modifications
exhibited
close
relationship
leukemia
regulating
cancer
pathways,
particularly
Hippo/Yap1
Wnt
(Wnt/β-catenin
Wnt/RhoA)
signalings
oxidatively
damaged
embryos.
Kdm6a
plasmid
antioxidant
EGCG
were
maintain
stability
antagonize
effects
ROS
on
Hippo
pathways.
concluded
loss
participated
via
oncogenic
RhoA/β-catenin
activation
tumor-suppressive
during
IVF.
or
hepatic
tumors
was
not
derived
from
further
analysis
revealed
play
crucial
role
pluripotency
embryonic
stem
cells.
antagonized
formation
rosette-like
structures
naive
gene
Oct4
as
well
primed
Otx2
implies
essentail
for
naive-to-primed
transition
blastocysts
implantation.
hypothesize
adversely
affects
blastocyst
implantation,
thereby
prevent
birth
tumorigenesis.
Language: Английский
A review of recent studies on the pathogenesis of Systemic Sclerosis: focus on fibrosis pathways
Sergio A. Jiménez,
No information about this author
Fabian A. Mendoza,
No information about this author
Sonsoles Piera‐Velazquez
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 16, 2025
Systemic
Sclerosis
(SSc)
is
a
systemic
autoimmune
disease
of
unknown
etiology
characterized
by
the
development
frequently
progressive
cutaneous
and
internal
organ
fibrosis
accompanied
severe
vascular
alterations.
The
pathogenesis
SSc
highly
complex
and,
despite
extensive
investigation,
has
not
been
fully
elucidated.
Numerous
studies
have
suggested
that
etiologic
factors
cause
multiple
alterations
in
genetically
receptive
hosts,
leading
to
progression.
These
events
may
be
functionally
pathologically
interconnected
include:
1)
Structural
functional
microvascular
endothelial
cell
abnormalities;
2)
Severe
oxidative
stress
high
reactive
oxygen
species
(3);
Frequently
visceral
fibrosis;
4)
Transdifferentiation
various
types
into
activated
myofibroblasts,
cells
ultimately
responsible
for
fibrotic
process;
5)
Establishment
chronic
inflammatory
process
affected
tissues;
6)
Release
cytokines,
chemokines,
growth
from
cells;
7)
Abnormalities
humoral
cellular
immunity
with
production
specific
autoantibodies;
8)
Epigenetic
including
changes
non-coding
RNAs.
manifest
different
levels
intensity
organs
display
remarkable
individual
variability,
resulting
wide
heterogeneity
extent
severity
clinical
manifestations.
Here,
we
will
review
some
recent
related
pathogenesis.
Language: Английский
Der große Unterschied
Michael Groß
No information about this author
Nachrichten aus der Chemie,
Journal Year:
2025,
Volume and Issue:
73(5), P. 77 - 79
Published: April 30, 2025
Abstract
Geschlechter‐Unterschiede
sind
in
der
Medizin
relevant,
etwa
im
Immunsystem,
bei
Herzinfarkten
und
Wirkung
von
Medikamenten.
Und
sie
zu
lange
vernachlässigt
worden.
Es
bleibt
noch
einiges
verbessern,
bis
jede:r
die
richtige
Behandlung
bekommt.
Mechanosensing regulates pDC activation in the skin through NRF2 activation
The Journal of Experimental Medicine,
Journal Year:
2024,
Volume and Issue:
222(3)
Published: Dec. 13, 2024
Plasmacytoid
DCs
(pDCs)
infiltrate
the
skin,
chronically
produce
type
I
interferon
(IFN-I),
and
promote
skin
lesions
fibrosis
in
autoimmune
patients.
However,
what
controls
their
activation
is
unknown.
Here,
we
report
that
increased
stiffness
inhibits
production
of
IFN-I
by
pDCs.
Mechanistically,
mechanosensing
activates
stress
pathways
including
NRF2,
which
induces
pentose
phosphate
pathway
reduces
pyruvate
levels,
a
product
necessary
for
pDC
responses.
Modulating
NRF2
activity
vivo
controlled
response,
leading
to
resolution
or
chronic
induction
skin.
In
systemic
sclerosis
(SSc)
patients,
although
was
induced
skin-infiltrating
pDCs,
as
compared
with
blood
IFN
response
maintained.
We
observed
CXCL4,
profibrotic
chemokine
elevated
fibrotic
able
overcome
stiffness-mediated
inhibition,
allowing
responses
pDCs
Hence,
these
data
identify
novel
regulatory
mechanism
exerted
microenvironment
points
dysregulation
this
patients
inflammation
fibrosis.
Language: Английский